Figure 1
- ID
- ZDB-FIG-200410-8
- Publication
- He et al., 2020 - Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
- Other Figures
- (all 8)
- All Figure Page
- Back to All Figure Page
The morphology of uninjected, Whole‐mount FLT3 signaling was detected by Western blotting in 293FT cells transfected with The effect of FLT3 inhibitor quizartinib (Qui) on the dorsalization and axis duplication phenotype induced by Quantification of |
Gene: | |
---|---|
Fish: | |
Anatomical Term: | |
Stage: | Prim-5 |
Gene | Antibody | Fish | Conditions | Stage | Qualifier | Anatomy | Assay |
---|---|---|---|---|---|---|---|
col9a2 | AB | standard conditions | Prim-5 | ISH |
Fish: | |
---|---|
Observed In: | |
Stage: | Prim-5 |